OptiNose AS Selects BioClinica, Inc.'s Trident IWR, Optimizer and Imaging Core Lab Solutions

Published: Sep 08, 2011

NEWTOWN, Pa.--(BUSINESS WIRE)--BioClinica®, Inc. (NASDAQ: BIOC), a global provider of clinical trial management solutions, today announced that OptiNose, Inc. selected BioClinica Trident IWR, Optimizer clinical supplies forecasting, and Imaging Core Lab services for use in a series of clinical trials including several pivotal Phase III studies.

Back to news